{"id":"W2592367943","doi":"10.2147/hiv.s108756","title":"Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks","year":2017,"lang":"en","type":"article","venue":"HIV/AIDS - Research and Palliative Care","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"ViiV Healthcare; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Ritonavir; Atazanavir; Abacavir; Medicine; Adverse effect; Lamivudine; Internal medicine; Human immunodeficiency virus (HIV); Viral load; Gastroenterology; Virology; Antiretroviral therapy; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000685519,0.0005367581,0.0009986894,0.0003961858,0.0009227413,0.0001430682,0.0003074218,0.0002151372,0.00007989317],"category_scores_gemma":[0.0006055622,0.0003246222,0.0001031716,0.0004514249,0.001002576,0.000250699,0.0001493677,0.0004906808,0.00002577439],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000384989,"about_ca_system_score_gemma":0.001097156,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001575821,"about_ca_topic_score_gemma":0.0004214984,"domain_scores_codex":[0.996399,0.0002828251,0.0003975331,0.0008899069,0.001084995,0.0009457117],"domain_scores_gemma":[0.9955872,0.0008228489,0.000262664,0.0008950225,0.00186804,0.000564185],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09645427,0.0005402623,0.8763504,0.0007922299,0.001429952,0.0005449101,0.006533024,0.000001087835,0.004741941,0.0002230917,0.01013003,0.002258805],"study_design_scores_gemma":[0.1136558,0.04204181,0.624142,0.005291669,0.001457415,0.0001326227,0.02749699,0.000575078,0.1311492,0.0001274242,0.0516593,0.002270724],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887632,0.001098078,0.0005164592,0.0014977,0.00002190355,0.003245891,0.001262171,0.00007946172,0.00351514],"genre_scores_gemma":[0.927952,0.0003462683,0.004690747,0.00003742354,0.00006124622,0.0005422099,0.001319198,0.0001005437,0.06495035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2522084,"threshold_uncertainty_score":0.9999206,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0964436235399211,"score_gpt":0.3903596400252832,"score_spread":0.2939160164853621,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}